JP4885355B2 - 自己凝集性の連続フィラメントの不織ウェブ - Google Patents

自己凝集性の連続フィラメントの不織ウェブ Download PDF

Info

Publication number: JP4885355B2
Authority: JP; Japan
Prior art keywords: article; web; component; poly; glycolide
Prior art date: 1997-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

JP2000514685A

Other languages

English (en)

Japanese (ja)

Other versions

JP2001518364A (ja

Inventor

ケー．ハイエス，バイロン

Original Assignee

ゴアエンタープライズホールディングス，インコーポレイティド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-02

Filing date

1998-09-29

Publication date

2012-02-29

1998-09-29 Application filed by ゴアエンタープライズホールディングス，インコーポレイティド filed Critical ゴアエンタープライズホールディングス，インコーポレイティド

2001-10-16 Publication of JP2001518364A publication Critical patent/JP2001518364A/ja

2012-02-29 Application granted granted Critical

2012-02-29 Publication of JP4885355B2 publication Critical patent/JP4885355B2/ja

2018-09-29 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

229920000642 polymer Polymers 0.000 claims description 173
238000000034 method Methods 0.000 claims description 67
239000000853 adhesive Substances 0.000 claims description 55
230000001070 adhesive effect Effects 0.000 claims description 53
229920001400 block copolymer Polymers 0.000 claims description 53
239000007943 implant Substances 0.000 claims description 44
238000002844 melting Methods 0.000 claims description 42
230000008018 melting Effects 0.000 claims description 41
239000011230 binding agent Substances 0.000 claims description 37
239000000126 substance Substances 0.000 claims description 37
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 36
238000001125 extrusion Methods 0.000 claims description 29
230000000975 bioactive effect Effects 0.000 claims description 28
238000002156 mixing Methods 0.000 claims description 24
239000012867 bioactive agent Substances 0.000 claims description 22
239000000654 additive Substances 0.000 claims description 21
230000017423 tissue regeneration Effects 0.000 claims description 14
230000036961 partial effect Effects 0.000 claims description 10
-1 morphogen Substances 0.000 claims description 9
239000003102 growth factor Substances 0.000 claims description 8
229920000166 polytrimethylene carbonate Polymers 0.000 claims description 8
108090000623 proteins and genes Proteins 0.000 claims description 7
241000124008 Mammalia Species 0.000 claims description 6
239000003242 anti bacterial agent Substances 0.000 claims description 6
238000010128 melt processing Methods 0.000 claims description 6
102000004169 proteins and genes Human genes 0.000 claims description 6
239000005482 chemotactic factor Substances 0.000 claims description 5
108090000765 processed proteins & peptides Proteins 0.000 claims description 5
230000002138 osteoinductive effect Effects 0.000 claims 8
230000000735 allogeneic effect Effects 0.000 claims 4
230000000845 anti-microbial effect Effects 0.000 claims 4
239000004599 antimicrobial Substances 0.000 claims 4
230000003115 biocidal effect Effects 0.000 claims 4
239000008177 pharmaceutical agent Substances 0.000 claims 4
230000006798 recombination Effects 0.000 claims 3
238000005215 recombination Methods 0.000 claims 3
241000282412 Homo Species 0.000 claims 2
239000000835 fiber Substances 0.000 description 211
239000000463 material Substances 0.000 description 102
239000000203 mixture Substances 0.000 description 76
238000002425 crystallisation Methods 0.000 description 66
230000008025 crystallization Effects 0.000 description 65
229920001577 copolymer Polymers 0.000 description 46
229920000954 Polyglycolide Polymers 0.000 description 42
230000008569 process Effects 0.000 description 37
YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 36
229920001519 homopolymer Polymers 0.000 description 35
210000000988 bone and bone Anatomy 0.000 description 33
238000000926 separation method Methods 0.000 description 27
239000002904 solvent Substances 0.000 description 27
210000001519 tissue Anatomy 0.000 description 27
208000027418 Wounds and injury Diseases 0.000 description 25
239000000155 melt Substances 0.000 description 24
239000007787 solid Substances 0.000 description 23
230000006378 damage Effects 0.000 description 22
208000014674 injury Diseases 0.000 description 22
230000002269 spontaneous effect Effects 0.000 description 22
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
208000035475 disorder Diseases 0.000 description 21
238000001816 cooling Methods 0.000 description 20
230000007704 transition Effects 0.000 description 20
239000012528 membrane Substances 0.000 description 18
230000004888 barrier function Effects 0.000 description 17
229920006126 semicrystalline polymer Polymers 0.000 description 17
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
210000004027 cell Anatomy 0.000 description 16
238000000151 deposition Methods 0.000 description 15
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
238000006243 chemical reaction Methods 0.000 description 14
239000010410 layer Substances 0.000 description 14
238000004220 aggregation Methods 0.000 description 13
238000010438 heat treatment Methods 0.000 description 13
230000002829 reductive effect Effects 0.000 description 13
230000002776 aggregation Effects 0.000 description 12
238000007906 compression Methods 0.000 description 12
238000009472 formulation Methods 0.000 description 12
230000001965 increasing effect Effects 0.000 description 12
238000005054 agglomeration Methods 0.000 description 11
230000008901 benefit Effects 0.000 description 11
238000005191 phase separation Methods 0.000 description 11
239000011148 porous material Substances 0.000 description 11
238000010791 quenching Methods 0.000 description 11
238000011282 treatment Methods 0.000 description 11
241000282485 Vulpes vulpes Species 0.000 description 10
230000015572 biosynthetic process Effects 0.000 description 10
230000007547 defect Effects 0.000 description 10
239000004744 fabric Substances 0.000 description 10
230000003239 periodontal effect Effects 0.000 description 10
238000012360 testing method Methods 0.000 description 10
BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 9
230000006835 compression Effects 0.000 description 9
238000011156 evaluation Methods 0.000 description 9
238000001727 in vivo Methods 0.000 description 9
230000033001 locomotion Effects 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
238000012545 processing Methods 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
238000006731 degradation reaction Methods 0.000 description 8
230000008021 deposition Effects 0.000 description 8
230000000694 effects Effects 0.000 description 8
230000006870 function Effects 0.000 description 8
230000009477 glass transition Effects 0.000 description 8
230000010354 integration Effects 0.000 description 8
229920003023 plastic Polymers 0.000 description 8
239000004033 plastic Substances 0.000 description 8
238000006116 polymerization reaction Methods 0.000 description 8
230000015556 catabolic process Effects 0.000 description 7
238000005755 formation reaction Methods 0.000 description 7
230000000996 additive effect Effects 0.000 description 6
239000012620 biological material Substances 0.000 description 6
239000013078 crystal Substances 0.000 description 6
230000007423 decrease Effects 0.000 description 6
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
239000012299 nitrogen atmosphere Substances 0.000 description 6
239000004745 nonwoven fabric Substances 0.000 description 6
239000004014 plasticizer Substances 0.000 description 6
229920000117 poly(dioxanone) Polymers 0.000 description 6
229920000728 polyester Polymers 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
239000000047 product Substances 0.000 description 6
230000009467 reduction Effects 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
229920000428 triblock copolymer Polymers 0.000 description 6
LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 5
229920000331 Polyhydroxybutyrate Polymers 0.000 description 5
229920006125 amorphous polymer Polymers 0.000 description 5
230000010478 bone regeneration Effects 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
239000011248 coating agent Substances 0.000 description 5
238000000576 coating method Methods 0.000 description 5
210000002808 connective tissue Anatomy 0.000 description 5
238000009792 diffusion process Methods 0.000 description 5
230000014759 maintenance of location Effects 0.000 description 5
238000002074 melt spinning Methods 0.000 description 5
229920000218 poly(hydroxyvalerate) Polymers 0.000 description 5
238000007711 solidification Methods 0.000 description 5
230000008023 solidification Effects 0.000 description 5
238000009987 spinning Methods 0.000 description 5
241000700159 Rattus Species 0.000 description 4
206010061363 Skeletal injury Diseases 0.000 description 4
230000009471 action Effects 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000009286 beneficial effect Effects 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
239000003814 drug Substances 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
239000012530 fluid Substances 0.000 description 4
230000004927 fusion Effects 0.000 description 4
230000035876 healing Effects 0.000 description 4
230000001976 improved effect Effects 0.000 description 4
230000003993 interaction Effects 0.000 description 4
238000011068 loading method Methods 0.000 description 4
239000004005 microsphere Substances 0.000 description 4
239000000178 monomer Substances 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000005015 poly(hydroxybutyrate) Substances 0.000 description 4
229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 4
229920001610 polycaprolactone Polymers 0.000 description 4
229920002959 polymer blend Polymers 0.000 description 4
230000008929 regeneration Effects 0.000 description 4
238000011069 regeneration method Methods 0.000 description 4
230000008521 reorganization Effects 0.000 description 4
238000007493 shaping process Methods 0.000 description 4
239000000243 solution Substances 0.000 description 4
238000003756 stirring Methods 0.000 description 4
238000003860 storage Methods 0.000 description 4
239000000758 substrate Substances 0.000 description 4
238000001356 surgical procedure Methods 0.000 description 4
238000009864 tensile test Methods 0.000 description 4
229920002725 thermoplastic elastomer Polymers 0.000 description 4
238000012546 transfer Methods 0.000 description 4
238000009966 trimming Methods 0.000 description 4
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 3
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 3
229920005603 alternating copolymer Polymers 0.000 description 3
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
229910052782 aluminium Inorganic materials 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000006399 behavior Effects 0.000 description 3
230000008468 bone growth Effects 0.000 description 3
229940112869 bone morphogenetic protein Drugs 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
238000010276 construction Methods 0.000 description 3
229920000359 diblock copolymer Polymers 0.000 description 3
238000004090 dissolution Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 3
239000008187 granular material Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000005461 lubrication Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
229920000747 poly(lactic acid) Polymers 0.000 description 3
229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
239000004632 polycaprolactone Substances 0.000 description 3
239000004926 polymethyl methacrylate Substances 0.000 description 3
150000003077 polyols Chemical group 0.000 description 3
230000000171 quenching effect Effects 0.000 description 3
229920005604 random copolymer Polymers 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000008439 repair process Effects 0.000 description 3
230000001629 suppression Effects 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000002076 thermal analysis method Methods 0.000 description 3
229940070710 valerate Drugs 0.000 description 3
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
FUGYGGDSWSUORM-UHFFFAOYSA-N 4-hydroxystyrene Chemical compound OC1=CC=C(C=C)C=C1 FUGYGGDSWSUORM-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
229920000544 Gore-Tex Polymers 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
230000001143 conditioned effect Effects 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000013270 controlled release Methods 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
210000003275 diaphysis Anatomy 0.000 description 2
238000000113 differential scanning calorimetry Methods 0.000 description 2
LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000000578 dry spinning Methods 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000011049 filling Methods 0.000 description 2
239000011888 foil Substances 0.000 description 2
238000005227 gel permeation chromatography Methods 0.000 description 2
210000004195 gingiva Anatomy 0.000 description 2
239000003365 glass fiber Substances 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
238000007654 immersion Methods 0.000 description 2
238000002513 implantation Methods 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
239000004816 latex Substances 0.000 description 2
229920000126 latex Polymers 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000010309 melting process Methods 0.000 description 2
210000005036 nerve Anatomy 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000035699 permeability Effects 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
229920002755 poly(epichlorohydrin) Polymers 0.000 description 2
229920000139 polyethylene terephthalate Polymers 0.000 description 2
239000005020 polyethylene terephthalate Substances 0.000 description 2
239000004633 polyglycolic acid Substances 0.000 description 2
239000004626 polylactic acid Substances 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
229920001343 polytetrafluoroethylene Polymers 0.000 description 2
239000004810 polytetrafluoroethylene Substances 0.000 description 2
229920002635 polyurethane Polymers 0.000 description 2
239000004814 polyurethane Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000008707 rearrangement Effects 0.000 description 2
238000005057 refrigeration Methods 0.000 description 2
230000001172 regenerating effect Effects 0.000 description 2
230000003252 repetitive effect Effects 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
238000005096 rolling process Methods 0.000 description 2
239000002356 single layer Substances 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
238000010583 slow cooling Methods 0.000 description 2
238000007655 standard test method Methods 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
229920001897 terpolymer Polymers 0.000 description 2
238000010998 test method Methods 0.000 description 2
AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
238000011179 visual inspection Methods 0.000 description 2
239000011800 void material Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
239000002023 wood Substances 0.000 description 2
MFRCZYUUKMFJQJ-UHFFFAOYSA-N 1,4-dioxane-2,5-dione;1,3-dioxan-2-one Chemical compound O=C1OCCCO1.O=C1COC(=O)CO1 MFRCZYUUKMFJQJ-UHFFFAOYSA-N 0.000 description 1
IUPHTVOTTBREAV-UHFFFAOYSA-N 3-hydroxybutanoic acid;3-hydroxypentanoic acid Chemical compound CC(O)CC(O)=O.CCC(O)CC(O)=O IUPHTVOTTBREAV-UHFFFAOYSA-N 0.000 description 1
GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
229920013642 Biopol™ Polymers 0.000 description 1
241000282465 Canis Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920004937 Dexon® Polymers 0.000 description 1
206010052804 Drug tolerance Diseases 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
208000015371 Mandibular injury Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920001410 Microfiber Polymers 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
208000006735 Periostitis Diseases 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
229920001244 Poly(D,L-lactide) Polymers 0.000 description 1
229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 description 1
239000004642 Polyimide Substances 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010009736 Protein Hydrolysates Proteins 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
239000004775 Tyvek Substances 0.000 description 1
229920000690 Tyvek Polymers 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000010062 adhesion mechanism Effects 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000002473 artificial blood Substances 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
238000005452 bending Methods 0.000 description 1
230000008275 binding mechanism Effects 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
229920000704 biodegradable plastic Polymers 0.000 description 1
238000006065 biodegradation reaction Methods 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
210000003010 carpal bone Anatomy 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000022261 cerebral cortex tangential migration using cell-cell interactions Effects 0.000 description 1
238000010516 chain-walking reaction Methods 0.000 description 1
229920006026 co-polymeric resin Polymers 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
239000011247 coating layer Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000007334 copolymerization reaction Methods 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000001938 differential scanning calorimetry curve Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000002745 epiphysis Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
OYQYHJRSHHYEIG-UHFFFAOYSA-N ethyl carbamate;urea Chemical compound NC(N)=O.CCOC(N)=O OYQYHJRSHHYEIG-UHFFFAOYSA-N 0.000 description 1
239000000284 extract Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
210000004744 fore-foot Anatomy 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000007429 general method Methods 0.000 description 1
230000026781 habituation Effects 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
238000007731 hot pressing Methods 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
229940027941 immunoglobulin g Drugs 0.000 description 1
230000003116 impacting effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000003999 initiator Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
238000009940 knitting Methods 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000013627 low molecular weight specie Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
230000001050 lubricating effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
210000004373 mandible Anatomy 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000010297 mechanical methods and process Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000003658 microfiber Substances 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000001565 modulated differential scanning calorimetry Methods 0.000 description 1
230000004001 molecular interaction Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
238000000465 moulding Methods 0.000 description 1
229920006030 multiblock copolymer Polymers 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
238000009828 non-uniform distribution Methods 0.000 description 1
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
239000011368 organic material Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
208000028169 periodontal disease Diseases 0.000 description 1
210000003460 periosteum Anatomy 0.000 description 1
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
229960002695 phenobarbital Drugs 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920001434 poly(D-lactide) Polymers 0.000 description 1
229920001432 poly(L-lactide) Polymers 0.000 description 1
229920001849 poly(hydroxybutyrate-co-valerate) Polymers 0.000 description 1
229940065514 poly(lactide) Drugs 0.000 description 1
229920001306 poly(lactide-co-caprolactone) Polymers 0.000 description 1
229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
229920001707 polybutylene terephthalate Polymers 0.000 description 1
229920001692 polycarbonate urethane Polymers 0.000 description 1
239000000622 polydioxanone Substances 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
229920001721 polyimide Polymers 0.000 description 1
229920006381 polylactic acid film Polymers 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
229920005597 polymer membrane Polymers 0.000 description 1
229920012287 polyphenylene sulfone Polymers 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000007712 rapid solidification Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
239000012783 reinforcing fiber Substances 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
230000004044 response Effects 0.000 description 1
238000007151 ring opening polymerisation reaction Methods 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
230000011218 segmentation Effects 0.000 description 1
238000001338 self-assembly Methods 0.000 description 1
230000035807 sensation Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
238000001998 small-angle neutron scattering Methods 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
MHQHHBYRYFICDV-UHFFFAOYSA-M sodium;pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1CC(=O)[N-]C(=O)N1 MHQHHBYRYFICDV-UHFFFAOYSA-M 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000002689 soil Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
239000007921 spray Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000003637 steroidlike Effects 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
239000012209 synthetic fiber Substances 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
229920006027 ternary co-polymer Polymers 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
238000002207 thermal evaporation Methods 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
229920001187 thermosetting polymer Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1
235000015149 toffees Nutrition 0.000 description 1
238000005809 transesterification reaction Methods 0.000 description 1
210000000623 ulna Anatomy 0.000 description 1
238000009827 uniform distribution Methods 0.000 description 1
238000009941 weaving Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1

Images

Classifications

- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/02—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments
- D04H3/03—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments at random
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/08—Melt spinning methods
- D01D5/098—Melt spinning methods with simultaneous stretching
- D01D5/0985—Melt spinning methods with simultaneous stretching by means of a flowing gas (e.g. melt-blowing)
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/78—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from copolycondensation products
- D01F6/84—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from copolycondensation products from copolyesters
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/005—Synthetic yarns or filaments
- D04H3/009—Condensation or reaction polymers
- D04H3/011—Polyesters
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/02—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments
- D04H3/07—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments otherwise than in a plane, e.g. in a tubular way
- D04H3/077—Stick, rod or solid cylinder shaped
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/08—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating
- D04H3/14—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating with bonds between thermoplastic yarns or filaments produced by welding
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1372—Randomly noninterengaged or randomly contacting fibers, filaments, particles, or flakes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/1376—Foam or porous material containing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/249921—Web or sheet containing structurally defined element or component
- Y10T428/249924—Noninterengaged fiber-containing paper-free web or sheet which is not of specified porosity
- Y10T428/249928—Fiber embedded in a ceramic, glass, or carbon matrix

Landscapes

Engineering & Computer Science (AREA)
Textile Engineering (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Mechanical Engineering (AREA)
General Chemical & Material Sciences (AREA)
Materials For Medical Uses (AREA)
Nonwoven Fabrics (AREA)
Prostheses (AREA)

JP2000514685A 1997-10-02 1998-09-29 自己凝集性の連続フィラメントの不織ウェブ Expired - Lifetime JP4885355B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/942,371		1997-10-02
US08/942,371 US6165217A (en)	1997-10-02	1997-10-02	Self-cohering, continuous filament non-woven webs
PCT/US1998/020411 WO1999017817A1 (fr)	1997-10-02	1998-09-29	Tissus non tisses a filaments continus auto-agglomerables

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2011023100A Division JP2011136181A (ja)	1997-10-02	2011-02-04	自己凝集性の連続フィラメントの不織ウェブ

Publications (2)

Publication Number	Publication Date
JP2001518364A JP2001518364A (ja)	2001-10-16
JP4885355B2 true JP4885355B2 (ja)	2012-02-29

Family

ID=25477998

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2000514685A Expired - Lifetime JP4885355B2 (ja)	1997-10-02	1998-09-29	自己凝集性の連続フィラメントの不織ウェブ
JP2011023100A Pending JP2011136181A (ja)	1997-10-02	2011-02-04	自己凝集性の連続フィラメントの不織ウェブ

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2011023100A Pending JP2011136181A (ja)	1997-10-02	2011-02-04	自己凝集性の連続フィラメントの不織ウェブ

Country Status (8)

Country	Link
US (3)	US6165217A (fr)
EP (1)	EP1023093B1 (fr)
JP (2)	JP4885355B2 (fr)
AU (1)	AU9512098A (fr)
CA (1)	CA2304992C (fr)
DE (1)	DE69819928T2 (fr)
ES (1)	ES2209212T3 (fr)
WO (1)	WO1999017817A1 (fr)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9814609D0 (en) *	1998-07-07	1998-09-02	Smith & Nephew	Polymers
DE19912360A1 (de) *	1999-03-19	2000-09-21	Aesculap Ag & Co Kg	Strangförmiges Implantat aus resorbierbarem Polymermaterial, Verfahren zu seiner Herstellung und Anwendung in der Chirurgie
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
US20020095157A1 (en)	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US7947069B2 (en) *	1999-11-24	2011-05-24	University Of Washington	Medical devices comprising small fiber biomaterials, and methods of use
DE19959088A1 (de) *	1999-12-08	2001-06-13	Inst Textil & Faserforschung	Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung
US6719987B2 (en) *	2000-04-17	2004-04-13	Nucryst Pharmaceuticals Corp.	Antimicrobial bioabsorbable materials
US20030003834A1 (en) *	2000-11-20	2003-01-02	3M Innovative Properties Company	Method for forming spread nonwoven webs
IL155787A0 (en) *	2000-11-20	2003-12-23	3M Innovative Properties Co	Fiber-forming process
CA2365376C (fr)	2000-12-21	2006-03-28	Ethicon, Inc.	Utilisation d'implants en mousse renforces ayant une meilleure integrite pour la reparation et la regeneration de tissus mous
US7192604B2 (en)	2000-12-22	2007-03-20	Ethicon, Inc.	Implantable biodegradable devices for musculoskeletal repair or regeneration
SE525131C2 (sv) *	2001-01-15	2004-12-07	Artimplant Ab	Implantat för rekonstruktion av leder
US6783554B2 (en)	2001-02-20	2004-08-31	Atrium Medical Corporation	Pile mesh prosthesis
US6827743B2 (en) *	2001-02-28	2004-12-07	Sdgi Holdings, Inc.	Woven orthopedic implants
US6599319B2 (en) *	2001-12-14	2003-07-29	Celanese Advanced Materials, Inc.	Prosthetic ligament
US7595111B2 (en) *	2002-02-20	2009-09-29	Joseph Dale Udy	Methods to continuous, monoatomic thick structures
US7128748B2 (en) *	2002-03-26	2006-10-31	Synovis Life Technologies, Inc.	Circular stapler buttress combination
US6923833B2 (en) *	2002-04-09	2005-08-02	Ray C. Wasielewski	Biologically reabsorbable acetabular constraining components and materials for use with a hip replacement prosthesis and bioreabsorbable materials to augment hip replacement stability and function
US20030211135A1 (en) *	2002-04-11	2003-11-13	Greenhalgh Skott E.	Stent having electrospun covering and method
US20040051201A1 (en) *	2002-04-11	2004-03-18	Greenhalgh Skott E.	Coated stent and method for coating by treating an electrospun covering with heat or chemicals
US20050187605A1 (en) *	2002-04-11	2005-08-25	Greenhalgh Skott E.	Electrospun skin capable of controlling drug release rates and method
US20030195611A1 (en) *	2002-04-11	2003-10-16	Greenhalgh Skott E.	Covering and method using electrospinning of very small fibers
US6916752B2 (en) *	2002-05-20	2005-07-12	3M Innovative Properties Company	Bondable, oriented, nonwoven fibrous webs and methods for making them
US7279440B2 (en) *	2002-05-20	2007-10-09	3M Innovative Properties Company	Nonwoven amorphous fibrous webs and methods for making them
US7824701B2 (en)	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
US20040078090A1 (en)	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
US7994078B2 (en) *	2002-12-23	2011-08-09	Kimberly-Clark Worldwide, Inc.	High strength nonwoven web from a biodegradable aliphatic polyester
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US20050038503A1 (en) *	2003-05-29	2005-02-17	Secor Medical, Llc	Filament based prosthesis
US7223518B2 (en) *	2003-06-06	2007-05-29	Georgia Tech Research Corporation	Compositions and methods of use thereof
US6991637B2 (en) *	2003-06-18	2006-01-31	Gore Enterprise Holdings, Inc.	Soft tissue defect repair device
US7776101B2 (en) *	2003-06-18	2010-08-17	Gore Enterprise Holdings, Inc.	Soft tissue defect repair device
US8226715B2 (en)	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en)	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
US20050059997A1 (en) *	2003-09-17	2005-03-17	Bauman Ann M.	Circular stapler buttress
US7547312B2 (en) *	2003-09-17	2009-06-16	Gore Enterprise Holdings, Inc.	Circular stapler buttress
US20050106982A1 (en) *	2003-11-17	2005-05-19	3M Innovative Properties Company	Nonwoven elastic fibrous webs and methods for making them
EP1684824B1 (fr)	2003-11-20	2015-08-12	The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Pompe manuelle portable pour evacuer des liquides
US7316822B2 (en)	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
US7901461B2 (en)	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
US20050131515A1 (en) *	2003-12-16	2005-06-16	Cully Edward H.	Removable stent-graft
US20050164598A1 (en) *	2004-01-22	2005-07-28	Mandalay Point, Inc.	Removable and reconfigurable doll clothing
US11395865B2 (en)	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8137686B2 (en) *	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
AU2005237985B2 (en)	2004-04-20	2010-10-21	Genzyme Corporation	Surgical mesh-like implant
US20050269011A1 (en) *	2004-06-02	2005-12-08	Ticona Llc	Methods of making spunbonded fabrics from blends of polyarylene sulfide and a crystallinity enhancer
US8562633B2 (en)	2004-08-02	2013-10-22	W. L. Gore & Associates, Inc.	Tissue repair device with a bioabsorbable support member
US8337475B2 (en)	2004-10-12	2012-12-25	C. R. Bard, Inc.	Corporeal drainage system
CA2584698C (fr)	2004-10-20	2014-02-25	Ethicon, Inc.	Pansement hemostatique multicouche absorbable renforce et son procede de fabrication
US20060258995A1 (en) *	2004-10-20	2006-11-16	Pendharkar Sanyog M	Method for making a reinforced absorbable multilayered fabric for use in medical devices
JP5058808B2 (ja) *	2004-10-20	2012-10-24	エシコン・インコーポレイテッド	医療器具用の強化された吸収性複層布およびその製造方法
US9358318B2 (en)	2004-10-20	2016-06-07	Ethicon, Inc.	Method of making a reinforced absorbable multilayered hemostatic wound dressing
JP2008536539A (ja) *	2005-03-07	2008-09-11	ジョージアテックリサーチコーポレイション	組織再生のためのナノフィラメントの足場
BRPI0612350B8 (pt)	2005-05-04	2021-06-22	Etech Ag	elemento de união e material protético
WO2007002933A2 (fr) *	2005-06-28	2007-01-04	Stout Medical Group, Inc.	Microstructures en couches minces destinees a des applications cardiovasculaires
AU2012202897B2 (en) *	2005-07-29	2013-12-05	W. L. Gore & Associates, Inc.	Composite self-cohered web materials
US8048503B2 (en) *	2005-07-29	2011-11-01	Gore Enterprise Holdings, Inc.	Highly porous self-cohered web materials
US7850810B2 (en) *	2005-07-29	2010-12-14	Gore Enterprise Holdings, Inc.	Method of making porous self-cohered web materials
US20070027551A1 (en) *	2005-07-29	2007-02-01	Farnsworth Ted R	Composite self-cohered web materials
US7655288B2 (en) *	2005-07-29	2010-02-02	Gore Enterprise Holdings, Inc.	Composite self-cohered web materials
US20070155010A1 (en) *	2005-07-29	2007-07-05	Farnsworth Ted R	Highly porous self-cohered fibrous tissue engineering scaffold
US20070026040A1 (en) *	2005-07-29	2007-02-01	Crawley Jerald M	Composite self-cohered web materials
AU2006276044B2 (en) *	2005-07-29	2010-02-11	W. L. Gore & Associates, Inc.	Highly porous self-cohered web materials having haemostatic properties
US20070026039A1 (en) *	2005-07-29	2007-02-01	Drumheller Paul D	Composite self-cohered web materials
US7604668B2 (en) *	2005-07-29	2009-10-20	Gore Enterprise Holdings, Inc.	Composite self-cohered web materials
US7655584B2 (en) *	2005-07-29	2010-02-02	Gore Enterprise Holdings, Inc.	Highly porous self-cohered web materials
US20070036842A1 (en) *	2005-08-15	2007-02-15	Concordia Manufacturing Llc	Non-woven scaffold for tissue engineering
WO2007038643A1 (fr)	2005-09-26	2007-04-05	C.R. Bard, Inc.	Systèmes de raccord de cathéther
DE102005050560A1 (de) *	2005-10-17	2007-04-19	Technische Universität Dresden	Trägermaterial aus Fasern und Verfahren zu seiner Herstellung
US20080220042A1 (en) *	2006-01-27	2008-09-11	The Regents Of The University Of California	Biomolecule-linked biomimetic scaffolds
CN101410508B (zh) *	2006-01-27	2013-07-03	加利福尼亚大学董事会	仿生支架
US20080014244A1 (en) *	2006-07-13	2008-01-17	Gale David C	Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers
US7846361B2 (en)	2006-07-20	2010-12-07	Orbusneich Medical, Inc.	Bioabsorbable polymeric composition for a medical device
US7557167B2 (en)	2006-09-28	2009-07-07	Gore Enterprise Holdings, Inc.	Polyester compositions, methods of manufacturing said compositions, and articles made therefrom
US20080081323A1 (en) *	2006-09-29	2008-04-03	Daniel Keeley	Regenerative Medicine Devices and Melt-Blown Methods of Manufacture
US7959942B2 (en)	2006-10-20	2011-06-14	Orbusneich Medical, Inc.	Bioabsorbable medical device with coating
EP2073754A4 (fr)	2006-10-20	2012-09-26	Orbusneich Medical Inc	Composition polymère bioabsorbable et fond de dispositif médical
US20080107711A1 (en) *	2006-11-08	2008-05-08	Alexis Paul Shelokov	Bioabsorbable Implantable Material Fortified with Antibiotics for Localized Delivery of Drugs
US8802002B2 (en) *	2006-12-28	2014-08-12	3M Innovative Properties Company	Dimensionally stable bonded nonwoven fibrous webs
EP2131919A4 (fr) *	2007-04-02	2010-10-20	Georgia Tech Res Inst	Dispositif implantable destiné à communiquer avec le tissu biologique
GB2448363A (en) *	2007-04-13	2008-10-15	3M Innovative Properties Co	Tubular support of composite material
US20080300684A1 (en) *	2007-05-31	2008-12-04	Shelokov Alexis P	System and method for controlled delivery of bone morphogenic protein and other bone graft substitutes for bone formation, repair and healing
EP2160486A4 (fr) *	2007-06-19	2011-09-14	Ca Nat Research Council	Mat non tissé et son procédé de fabrication
JP5241841B2 (ja) *	2007-08-17	2013-07-17	ファイバーウェブ，インコーポレイテッド	単一のポリマー系から製造される区域接合された不織布
US20090112332A1 (en) *	2007-10-31	2009-04-30	Alexis Paul Shelokov	Bone graft and bone graft substitutes with antibiotics for sustained, localized release of antibiotics for reducing postoperative surgical wound infection in spinal and other bone surgery
US7713463B1 (en) *	2007-11-13	2010-05-11	Nuvasive, Inc.	Method of manufacturing embroidered surgical implants
US8142501B2 (en)	2008-04-21	2012-03-27	The Board Of Regents Of The University Of Texas System	Artificial ligaments and tendons comprising multifilaments and nanofibers and methods for making
CA2723785C (fr) *	2008-06-10	2017-08-22	Pathogen Removal And Diagnostic Technologies Inc.	Revetement enrobant de fibres polymeres sur des substrats non tisses
EP2962704A1 (fr) *	2008-10-07	2016-01-06	Nanonerve, Inc.	Supports polymères fibreux multicouches, procédés de production et procédés d'utilisation
BRPI0923754A2 (pt)	2008-12-30	2016-01-19	3M Innovative Properties Co	mantas fibrosas de não-tecido elástico e métodos para fabricação e uso das mesmas
JP5154473B2 (ja) *	2009-02-20	2013-02-27	三井化学株式会社	ブロック共重合体の解析方法およびブロック共重合体の製造方法
US8758447B2 (en) *	2009-06-30	2014-06-24	Ethicon, Inc.	Device and method for repair of urological structures
US20100331963A1 (en) *	2009-06-30	2010-12-30	Jackie Donners	Method of Making Suture-Less Hollow Scaffolds
US8162153B2 (en)	2009-07-02	2012-04-24	3M Innovative Properties Company	High loft spunbonded web
BR112012010678A2 (pt) *	2009-11-05	2019-09-24	Nonwotecc Medical Gmbh	tecido não tecido para uso médico e processo para sua preparação
WO2011133183A1 (fr) *	2010-04-20	2011-10-27	University Of Utah Research Foundation	Échafaudage pulvérisé à séparation de phase
RU2535040C2 (ru) *	2010-07-02	2014-12-10	Дзе Проктер Энд Гэмбл Компани	Способы доставки медицинского активного агента путем введения индивидуальных медицинских изделий, содержащих филамент
WO2012019049A1 (fr)	2010-08-04	2012-02-09	Georgia Tech Research Corporation	Dispositifs, systèmes et procédés d'excavation de cellules cancéreuses
ES2575584T3 (es)	2010-09-09	2016-06-29	W. L. Gore & Associates, Inc.	Método para aumentar la resistencia mecánica al desgarro de una película
CN103179917A (zh)	2010-09-09	2013-06-26	W.L.戈尔及同仁股份有限公司	外科网
US8617240B2 (en)	2010-11-17	2013-12-31	Charles D. Hightower	Moldable cushion for implants
US9168231B2 (en)	2010-12-05	2015-10-27	Nanonerve, Inc.	Fibrous polymer scaffolds having diametrically patterned polymer fibers
US20130123816A1 (en) *	2011-11-10	2013-05-16	Gerald Hodgkinson	Hydrophilic medical devices
US20150328062A9 (en) *	2011-11-10	2015-11-19	Covidien Lp	Hydrophilic medical devices
BR112014019797B1 (pt) *	2012-02-10	2019-11-19	Synthes Gmbh	materiais de implante porosos e métodos relacionados
US9045362B2 (en)	2013-03-15	2015-06-02	Mosci Corp.	Bioactive glass scaffolds, and method of making
US8449904B1 (en)	2012-03-26	2013-05-28	Mosci, Corp.	Bioactive glass scaffolds, and method of making
US11225430B2 (en)	2012-03-26	2022-01-18	Steven Jung	Bioactive glass scaffolds, and method of making
US20140042706A1 (en)	2012-08-13	2014-02-13	Sika Technology Ag	Expanding material in nonwoven 3-d structure
US20140065090A1 (en) *	2012-08-31	2014-03-06	W. L. Gore & Associates, Inc.	Reactive Oxidative Species Generating Materials and Methods of Use
US9259435B2 (en) *	2012-08-31	2016-02-16	W. L. Gore & Associates, Inc.	Reactive oxidative species generating materials and methods of use
US9700311B2 (en)	2013-11-08	2017-07-11	Ethicon Llc	Tissue ingrowth materials and method of using the same
EP2883554A1 (fr) *	2013-12-16	2015-06-17	MeKo Laserstrahl-Materialbearbeitungen e.K.	Fabrication de tubes en polymère résorbable à partir de fils
US9738013B1 (en) *	2013-12-19	2017-08-22	Hrl Laboratories, Llc	Multi-chemistry microlattice structures and methods of manufacturing the same
US10835216B2 (en) *	2014-12-24	2020-11-17	Covidien Lp	Spinneret for manufacture of melt blown nonwoven fabric
US9737368B2 (en)	2015-02-24	2017-08-22	Abbott Cardiovascular Systems Inc.	System and method for attaching a radiopaque marker bead to an endoprosthesis
BR112017025980A2 (pt)	2015-06-02	2018-08-14	The Euclid Chemical Company	fibras com perfil de seção cruzada modificado
US10238388B2 (en) *	2015-10-29	2019-03-26	Ethicon Llc	Surgical stapler buttress assembly with humidity tolerant adhesive
JP7066642B2 (ja)	2016-07-18	2022-05-13	メリット・メディカル・システムズ・インコーポレイテッド	膨張式橈骨動脈圧縮装置
US11052230B2 (en)	2016-11-08	2021-07-06	W. L. Gore & Associates, Inc.	Implantable encapsulation devices
EP3354292A1 (fr)	2017-01-30	2018-08-01	MeKo Laserstrahl-Materialbearbeitungen e.K.	Fabrication de tubes en polymère résorbable composés de fils à plusieurs composants
KR102181642B1 (ko) *	2017-12-11	2020-11-23	아주대학교산학협력단	지방족 폴리카보네이트를 포함하는 바이오 프린팅용 생체 재료 및 이를 이용한 생체 구조체의 제조방법
US11590329B2 (en) *	2018-05-16	2023-02-28	Spirox, Inc.	Allergic rhinitis drug delivery implant
US10493233B1 (en)	2018-06-05	2019-12-03	Duke University	Bi-directional access to tumors
US11369473B2 (en)	2019-04-08	2022-06-28	Loubert S. Suddaby	Extended release immunomodulatory implant to facilitate bone morphogenesis
US11779683B2 (en)	2019-04-08	2023-10-10	Loubert S. Suddaby	Extended release immunomodulatory implant to facilitate bone morphogenesis
WO2022036002A1 (fr)	2020-08-13	2022-02-17	Merit Medical Systems, Inc.	Dispositif gonflable de compression d'artère radiale comprenant un bracelet de serrage et procédé d'utilisation
KR20230127321A (ko) *	2021-02-17	2023-08-31	아사히 가세이 가부시키가이샤	생분해성 부직포 및 성형체의 제조 방법
WO2022266605A1 (fr)	2021-06-18	2022-12-22	Merit Medical Systems, Inc.	Dispositifs d'hémostase et procédés d'utilisation
EP4596773A1 (fr) *	2022-09-28	2025-08-06	Kaneka Corporation	Procédé de production de tissu non tissé, et tissu non tissé de fusion-soufflage, corps fondu à chaud et son procédé de production, filtre à café, et capsule de café
WO2025147608A2 (fr)	2024-01-05	2025-07-10	W. L. Gore & Associates, Inc.	Échafaudage tissulaire implantable

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0263465A (ja) *	1988-08-31	1990-03-02	G C Dental Ind Corp	歯周組織再生用素材
JPH0450353A (ja) *	1990-06-08	1992-02-19	Toray Ind Inc	メルトブロー不織布
JPH05195407A (ja) *	1991-06-13	1993-08-03	Carl Freudenberg:Fa	熱塑性エンドレスフィラメントから成るスパンボンド不織布及びその製造方法
JPH05222656A (ja) *	1991-09-26	1993-08-31	Unitika Ltd	微生物分解性極細繊維不織布およびその製造方法
WO1994016135A1 (fr) *	1993-01-07	1994-07-21	Unitika Ltd	Fibre de liage et tissu non tisse produit a partir de celle-ci

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3875937A (en) *	1963-10-31	1975-04-08	American Cyanamid Co	Surgical dressings of absorbable polymers
US3839297A (en) *	1971-11-22	1974-10-01	Ethicon Inc	Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US3977440A (en) *	1972-05-03	1976-08-31	Samuel Moore And Company	Composite brake hose
CS175082B1 (fr) *	1974-08-28	1977-04-29
US4300565A (en) *	1977-05-23	1981-11-17	American Cyanamid Company	Synthetic polyester surgical articles
US4243775A (en) *	1978-11-13	1981-01-06	American Cyanamid Company	Synthetic polyester surgical articles
US4137921A (en) *	1977-06-24	1979-02-06	Ethicon, Inc.	Addition copolymers of lactide and glycolide and method of preparation
US4163819A (en) *	1977-12-27	1979-08-07	Monsanto Company	Drapeable nonwoven fabrics
DE2806030C2 (de) *	1978-02-14	1984-02-02	B. Braun Melsungen Ag, 3508 Melsungen	Verfahren zur Herstellung einer schlauchförmigen Blutgefäßprothese
US4211689A (en) *	1978-12-06	1980-07-08	General Electric Company	Copolyesters of polybutylene terephthalate
US4429080A (en) *	1982-07-01	1984-01-31	American Cyanamid Company	Synthetic copolymer surgical articles and method of manufacturing the same
US4916193A (en) *	1987-12-17	1990-04-10	Allied-Signal Inc.	Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
DE3853591T2 (de) *	1987-12-17	1995-09-14	United States Surgical Corp	Medizinische anordnungen, hergestellt aus homo- und kopolymeren mit wiederkehrender karbonateinheiten.
US4920203A (en) *	1987-12-17	1990-04-24	Allied-Signal Inc.	Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
US4910064A (en) *	1988-05-25	1990-03-20	Sabee Reinhardt N	Stabilized continuous filament web
US5080665A (en) *	1990-07-06	1992-01-14	American Cyanamid Company	Deformable, absorbable surgical device
US5252701A (en) *	1990-07-06	1993-10-12	American Cyanamid Company	Segmented absorbable copolymer
WO1992010218A1 (fr) *	1990-12-06	1992-06-25	W.L. Gore & Associates, Inc.	Article bioabsorbable implantable
CA2060635A1 (fr) *	1991-02-12	1992-08-13	Keith D'alessio	Implants medicaux bioabsorbables
SE9100610D0 (sv) *	1991-03-04	1991-03-04	Procordia Ortech Ab	Bioresorbable material for medical use
US5328758A (en) *	1991-10-11	1994-07-12	Minnesota Mining And Manufacturing Company	Particle-loaded nonwoven fibrous article for separations and purifications
US5470639A (en) *	1992-02-03	1995-11-28	Fiberweb North America, Inc.	Elastic nonwoven webs and method of making same
US5433909A (en) *	1992-03-13	1995-07-18	Atrium Medical Corporation	Method of making controlled porosity expanded polytetrafluoroethylene products
US5514378A (en) *	1993-02-01	1996-05-07	Massachusetts Institute Of Technology	Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
CA2105026C (fr) *	1993-04-29	2003-12-16	Henry Louis Griesbach Iii	Non-tisse forme et sa methode de fabrication
US5393594A (en) *	1993-10-06	1995-02-28	United States Surgical Corporation	Absorbable non-woven fabric
US5681873A (en) *	1993-10-14	1997-10-28	Atrix Laboratories, Inc.	Biodegradable polymeric composition
US5505952A (en) *	1994-04-19	1996-04-09	United States Surgical Corporation	Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
US5582907A (en) *	1994-07-28	1996-12-10	Pall Corporation	Melt-blown fibrous web
US5656205A (en) *	1994-12-29	1997-08-12	International Business Machines Corporation	Optical components from phase separated block polymers
DE19654884C2 (de) *	1996-03-04	1999-07-29	Kirsch Axel	Formkörper
US5788674A (en)	1996-03-05	1998-08-04	Medication Delivery Devices, Inc.	Apparatus and method for limiting free-flow in an infusion system
US5851229A (en) *	1996-09-13	1998-12-22	Meadox Medicals, Inc.	Bioresorbable sealants for porous vascular grafts
DE19641334A1 (de) *	1996-10-08	1998-04-09	Inst Textil & Faserforschung	Triblockterpolymer, seine Verwendung für medizinische Produkte und Verfahren zur Herstellung

1997
- 1997-10-02 US US08/942,371 patent/US6165217A/en not_active Expired - Lifetime
1998
- 1998-09-29 EP EP98948575A patent/EP1023093B1/fr not_active Expired - Lifetime
- 1998-09-29 DE DE69819928T patent/DE69819928T2/de not_active Expired - Lifetime
- 1998-09-29 JP JP2000514685A patent/JP4885355B2/ja not_active Expired - Lifetime
- 1998-09-29 AU AU95120/98A patent/AU9512098A/en not_active Abandoned
- 1998-09-29 ES ES98948575T patent/ES2209212T3/es not_active Expired - Lifetime
- 1998-09-29 WO PCT/US1998/020411 patent/WO1999017817A1/fr not_active Ceased
- 1998-09-29 CA CA002304992A patent/CA2304992C/fr not_active Expired - Lifetime
2000
- 2000-12-05 US US09/730,643 patent/US20010000352A1/en not_active Abandoned
- 2000-12-05 US US09/730,644 patent/US6309423B2/en not_active Expired - Lifetime
2011
- 2011-02-04 JP JP2011023100A patent/JP2011136181A/ja active Pending

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0263465A (ja) *	1988-08-31	1990-03-02	G C Dental Ind Corp	歯周組織再生用素材
JPH0450353A (ja) *	1990-06-08	1992-02-19	Toray Ind Inc	メルトブロー不織布
JPH05195407A (ja) *	1991-06-13	1993-08-03	Carl Freudenberg:Fa	熱塑性エンドレスフィラメントから成るスパンボンド不織布及びその製造方法
JPH05222656A (ja) *	1991-09-26	1993-08-31	Unitika Ltd	微生物分解性極細繊維不織布およびその製造方法
WO1994016135A1 (fr) *	1993-01-07	1994-07-21	Unitika Ltd	Fibre de liage et tissu non tisse produit a partir de celle-ci

Also Published As

Publication number	Publication date
JP2011136181A (ja)	2011-07-14
CA2304992C (fr)	2006-06-20
AU9512098A (en)	1999-04-27
EP1023093A1 (fr)	2000-08-02
DE69819928T2 (de)	2004-11-04
US20010000189A1 (en)	2001-04-05
DE69819928D1 (de)	2003-12-24
US6165217A (en)	2000-12-26
CA2304992A1 (fr)	1999-04-15
WO1999017817A1 (fr)	1999-04-15
JP2001518364A (ja)	2001-10-16
US6309423B2 (en)	2001-10-30
ES2209212T3 (es)	2004-06-16
US20010000352A1 (en)	2001-04-19
EP1023093B1 (fr)	2003-11-19

Legal Events

Date	Code	Title	Description
2005-09-20	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050916
2009-06-24	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090623
2009-09-19	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090918
2009-10-01	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090930
2009-12-25	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091224
2010-10-06	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101005
2011-02-05	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110204
2011-02-23	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110222
2011-04-13	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110412
2011-07-12	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110711
2011-07-20	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110719
2011-10-13	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111012
2011-10-31	TRDD	Decision of grant or rejection written
2011-11-09	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111108
2011-11-10	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2011-12-15	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111208
2011-12-16	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20141216 Year of fee payment: 3
2011-12-16	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2014-12-16	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2015-06-29	S111	Request for change of ownership or part of ownership	Free format text: JAPANESE INTERMEDIATE CODE: R313113
2015-07-07	R350	Written notification of registration of transfer	Free format text: JAPANESE INTERMEDIATE CODE: R350
2015-12-08	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2016-12-06	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2017-12-12	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2018-09-29	EXPY	Cancellation because of completion of term

Publication	Publication Date	Title
JP4885355B2 (ja)	2012-02-29	自己凝集性の連続フィラメントの不織ウェブ
JP5706498B2 (ja)	2015-04-22	複合自己凝集ウェブ材料
JP5405826B2 (ja)	2014-02-05	高多孔質自己凝集ウェブ材料
AU2003204210B2 (en)	2007-06-07	Attachment of absorbable tissue scaffolds to fixation devices
US7659219B2 (en)	2010-02-09	Highly porous self-cohered web materials having haemostatic properties
US7604668B2 (en)	2009-10-20	Composite self-cohered web materials
US8048500B2 (en)	2011-11-01	Composite self-cohered web materials
JP2010516395A (ja)	2010-05-20	高多孔質自己凝集繊維質組織工学足場
US20070026031A1 (en)	2007-02-01	Composite self-cohered web materials
JP2009505690A (ja)	2009-02-12	複合自己凝集ウェブ材料
JP5015925B2 (ja)	2012-09-05	多孔質自己凝集ウェブ材料の製造方法